miscentertainmentcorporateresearchwellnessathletics

RBC Capital Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)


RBC Capital Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

Filter, analyze, and streamline your search for investment opportunities with TipRanks' Stock Screener.

According to TipRanks, Wong-Pan is a 2-star analyst with an average return of -0.2% and a 48.28% success rate. Wong-Pan covers the Healthcare sector, focusing on stocks such as Nanosonics Limited, Ansell, and Cochlear Limited.

Integral Diagnostics Ltd. has an analyst consensus of Strong Buy, with a price target consensus of A$3.27, representing a 42.17% upside. In a report released yesterday, Jefferies also maintained a Buy rating on the stock with a A$3.60 price target.

IDX market cap is currently A$933.3M and has a P/E ratio of 103.29.

Previous articleNext article

POPULAR CATEGORY

misc

18156

entertainment

20268

corporate

17097

research

10299

wellness

16884

athletics

21279